Step by Step


ABIM MOC Activity ID

8/18/2020 - Medical Grand Rounds: COVID-19 Vaccine Development and Implementation





Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Improve knowledge of vaccine development process.
  • Learn current status of COVID-19 vaccines.
  • Increase patient acceptance of safe and effective COVID vaccine.

Suggested Additional Reading & Joint Accreditation Statement:

Suggested Reading:

  3. Pedro M Folegatti*, Katie J Ewer*, Parvinder K Aley, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 2020;
  4. L.A. Jackson, E.J. Anderson, N.G. Rouphael, et al. An mRNA Vaccine against SARS-CoV-2 —Preliminary Report. NEJM 2020; DOI: 10.1056/NEJMoa2022483
  5. Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science 2020;368:948-50

Joint Accrediation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Judith M. Martin, MD — Pediatric Infectious Disease Specialist in Pittsburgh, Pennsylvania
No relationships with industry relevant to the content of this educational activity have been disclosed.
Paul Duprex, PhD — CVR Director and Jonas Salk Chair for Vaccine Research, University of Pittsburgh
No relationships with industry relevant to the content of this educational activity have been disclosed.
Sharon A. Riddler, MD — Director, Clinical Research, Infectious Diseases Division, Co-Principal Investigator, Pitt-Ohio State Clinical Trials Unit, Member, AIDS Clinical Trials Group (ACTG) Executive Committee, University of Pittsburgh School of Medicine.
Dr. Fiddler receives grant/research support from GlaxoSmithKline; Gilead Sciences and Merck. She is a consultant with Novamab.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The University of Pittsburgh is an affirmative action, equal opportunity institution.